Sosei Financial Statements From 2010 to 2025
| SOLTF Stock | USD 6.20 0.19 2.97% |
Check Sosei Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sosei Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sosei financial statements analysis is a perfect complement when working with Sosei Group Valuation or Volatility modules.
Sosei |
Sosei Group Company Return On Equity Analysis
Sosei Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sosei Group Return On Equity | -0.007 |
Most of Sosei Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sosei Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sosei Group has a Return On Equity of -0.007. This is 99.97% lower than that of the Healthcare sector and 99.98% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 97.74% lower than that of the firm.
Sosei Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sosei Group's current stock value. Our valuation model uses many indicators to compare Sosei Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sosei Group competition to find correlations between indicators driving Sosei Group's intrinsic value. More Info.Sosei Group is rated second in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sosei Group's earnings, one of the primary drivers of an investment's value.About Sosei Group Financial Statements
Sosei Group stakeholders use historical fundamental indicators, such as Sosei Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sosei Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sosei Group's assets and liabilities are reflected in the revenues and expenses on Sosei Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sosei Group. Please read more on our technical analysis and fundamental analysis pages.
Sosei Group Corporation develops biopharmaceutical products worldwide. The company was incorporated in 1990 and is headquartered in Tokyo, Japan. Sosei operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 205 people.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Sosei Pink Sheet
Sosei Group financial ratios help investors to determine whether Sosei Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sosei with respect to the benefits of owning Sosei Group security.